Cardiac Prosthetic Devices Market Report, Share, Size, Growth and Forecast Till 2025


Posted July 1, 2020 by imarcgroup1

Cardiac prosthetic devices refer to artificial devices that are implanted permanently or temporarily for repairing and replacing damaged heart tissues.

 
Cardiac prosthetic devices are artificial devices implanted temporarily or permanently for supporting the proper functioning of damaged heart tissues. They are also used for maintaining blood flow, preventing blockage in arteries and improving the overall quality of life in patients. Some of the commonly utilized cardiac prosthetic devices include pacemakers, ventricular assist devices, defibrillators, annuloplasty rings and heart valves.

Some of the key players operating in the market include Abbott Laboratories (ABT), St. Jude Medical Inc. (STJ), Boston Scientific Corporation (BCX), Edwards Lifesciences Corporation (EW), Medtronic Inc (MDT)., Meril Life Sciences Pvt. Ltd., Siemens Healthcare GmbH (SHL), Sorin Group, Biotronik, Lepu Medical Technology Co. Ltd.,etc.

Request for a free sample report: https://www.imarcgroup.com/cardiac-prosthetic-devices-market/requestsample

On account of the sedentary lifestyles and unhealthy dietary patterns, there is an increase in the prevalence of cardiovascular diseases (CVDs) and other heart ailments, such as coronary artery disease (CAD). This represents one of the significant factors bolstering the growth of the cardiac prosthetic devices market. Moreover, advancements in heart valve replacement devices and the introduction of compact-sized pacemakers are impelling the market growth. Other factors, such as the rising trend of minimally invasive surgery (MIS), growing geriatric population and extensive research and development (R&D) activities, are expected to drive the market further in the coming years.

Browse full report with TOC: https://www.imarcgroup.com/cardiac-prosthetic-devices-market

Cardiac Prosthetic Devices Market Segmentation

Breakup by Product Type:

• Valves
o Mechanical Valve
o Tissue Valve
o Stented Tissue Valve
o Stentless Tissue Valve
o Transcatheter Valve
• Pacemakers
• Implantable Pacemakers
o Single-Chamber Battery Pacemaker
o Dual-Chamber Battery Pacemaker
o Triple-Chamber Battery Pacemaker
• External Pacemakers
• Others

Breakup by End-User:

• Hospitals, Clinics and Cardiac Centers
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: [email protected]
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By IMARC Group
Phone 6317911145
Business Address 30 N Gould St, Ste R
Sheridan, WY 82801
Country United States
Categories Health , Industry , Research
Tags cardiac prosthetic devices , cardiac prosthetic devices market forecast , cardiac prosthetic devices market report , cardiac prosthetic devices market share , cardiac prosthetic devices market size
Last Updated July 1, 2020